section 8
on 19 Jan 2024
Last Applicant/ Owned by
114-2, 36, Dongsanjae-gil, Bongdam-eup
Hwaseong-si
KR
Serial Number
87088329 filed on 29th Jun 2016
Registration Number
5235255 registered on 04th Jul 2017
Filing Basis
1. filed as use application
2. use application currently
Disclaimer
NO DATA
The non-Latin characters in the mark transliterate to "red kleo" and this means "red cleo" in English. Color is not claimed as a feature of the mark. Health food supplements consisting primarily of pomegranate extract; Health food supplements consisting primarily of garsinia canbogia; Health food supplements consisting primarily of vitamin D; Health food supplements consisting primarily of vitamRead More
Health food supplements consisting primarily of pomegranate extract; Health food supplements consisting primarily of garsinia canbogia; Health food supplements consisting primarily of vitamin D; Health food supplements consisting primarily of vitamin E; Health food supplements consisting primarily of zinc
30th Nov 2015
14th Jun 2016
No 87088329
No Service/Collective Mark
No 212450.00003
No
No
No
No
No
No
No
No
24.11.01 -
Crowns closed at the top
28.01.03 -
Japanese and Chinese characters Formerly Inscriptions in Chinese, Japanese, Korean, Vietnamese or other Asian characters
28.01.04 -
Korean Hangul
The mark consists of Korean characters with the words "RED CLEO" underneath the last Korean character. The last Korean character has a stylized crown at the top right.
| Status Date | Action Taken |
|---|---|
| 19th Jan 2024 | CANCELLED SEC. 8 (6-YR) |
| 04th Jul 2022 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED |
| 04th Jul 2017 | REGISTERED-PRINCIPAL REGISTER |
| 18th Apr 2017 | PUBLISHED FOR OPPOSITION |
| 18th Apr 2017 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| 29th Mar 2017 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| 16th Mar 2017 | LAW OFFICE PUBLICATION REVIEW COMPLETED |
| 04th Mar 2017 | ASSIGNED TO LIE |
| 17th Feb 2017 | EXAMINERS AMENDMENT -WRITTEN |
| 17th Feb 2017 | EXAMINERS AMENDMENT E-MAILED |
